From conversation to source of truth.

Watch what the peptide world is saying, then see what the published evidence actually supports. Community experience stays clearly separate from research.

Join PEPTD Start watching

Watch

See what's happening.

The freshest relevance-ranked video intelligence from the peptide world — real creators, summarised and cross-linked to the compounds they discuss. Playback stays inside PEPTD.

Tirzepatide
CJC-1295
GHK-Cu

Tirzepatide & The Brain: Stopping a "Brain Attack" Before It Starts

Doctor Michael MuellerSep 8, 2026

Why it matters · PEPTD AI summary

This educational video by Doctor Michael Mueller discusses Tirzepatide's potential neuroprotective effects beyond weight loss and blood sugar control. The creator interprets that dual GIP/GLP-1 receptor activation, as seen with Tirzepatide, may significantly reduce ischemic stroke risk, improve blood-brain barrier integrity, and lower cognitive decline risk by stabilizing arterial plaque, reducing neuroinflammation, and preserving mitochondrial health. The video refers to a study by Dr. Nathan D. Wong.

Physician commentaryYouTube · plays inside PEPTD

Watch

MOTS-c
Retatrutide

Doctor Explains the Best Retatrutide Alternatives (AOD, MOTS c, SLUPP332 & More)

Dr. Jones, DCSep 7, 2026

Why it matters · PEPTD AI summary

Dr. Jones, DC, discusses why multi-receptor peptides like Retatrutide might not drive weight loss for some, introducing the 'Glucagon Effect' and a 'Three-System Peptide Framework'. The video explores targeted peptide layers including AOD-9604, SLU-PP-332, MOTS-c, and O-304, differentiating between fat mobilization, appetite suppression, and cellular enhancement.

Physician commentaryYouTube · plays inside PEPTD

Watch

Open Watch

Learn

Understand what the evidence says.

One subject at a time, translated into a graded intelligence card: what the research supports, what is still open, and where the sources are.

Learn intelligence card · Healing

BPC-157

Clinical Trial Only

Takeaway

Studied in animal models for tissue repair. Human evidence is limited.

Peer-reviewed research3 studies
Clinical registry2 trials
Creator commentary186 video briefings

What we know

Reported in preclinical studies to influence angiogenesis, growth factor expression, and nitric oxide pathways involved in tissue repair.

What remains uncertain

Long-term human safety, optimal route of administration, and effective dose ranges are not established.

Known risks · Not approved for human use by FDA. Human safety data is limited.

Key indexed sources

Registered trialBPC 157 for Acute Hamstring Muscle Strain Repair
Registered trialA Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
Peer-reviewedEffects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.

Reviewed Jun 13, 2026Educational summary · not medical advice

Explore evidence

Open Learn

Explore goals

Start with the outcome you care about.

You shouldn't need to know a compound name to get anywhere. Pick a goal and PEPTD opens the world behind it — the compounds people explore for it, the research, and the community context.

Explore goals

Industry Pulse

Questions moving through the peptide world.

Recurring public questions and concerns, paraphrased and routed to the video, research or tool that actually helps.

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Common questionReconstitution & dosing math

How do I know whether my reconstitution math is actually right?

Reconstitution math is one of the most persistent sources of confusion in public peptide discussions — people repeatedly ask others to sanity-check mg, mL and syringe-unit conversions before drawing anything.

ReconstitutionSyringe unitsBeginner

WatchSee it explained BuildOpen the calculator CommunityJoin the discussion

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Captured from r/Peptidesource

Public concernBPC-157 debates